PHOENIX, Feb. 19, 2013 /PRNewswire/ -- Endexx
Corporation (OTC Markets: EDXC) announces that it has entered into
a Letter of Agreement and Memorandum of Understanding to purchase
and acquire from Hayes Pharmacy Inc. (a Texas Corporation), the
exclusive operating technology, intellectual property, marketing
and ownership rights to a proprietary pharmaceutical/pharmacy
compliance, controls, privacy, verification and operations
platform. The platform is specifically designed to service the
medical marijuana industry and long term chronic pharmaceutical
patient care arena. Upon completion of due diligence and closing of
the transaction, Endexx will report details of the business going
forward.
Contact: Todd Davis CEO
EndexxCorporation@yahoo.com
http://www.otcmarkets.com/stock/EDXC/quote
www.endexx.com
Safe Harbor Statement
This press release contains forward-looking information within
the meaning of Section 21E of the Securities Exchange Act of 1934,
as amended (the "Exchange Act"), including statements regarding
potential sales, the success of the company's business, as well as
statements that include the word "believe" or similar expressions.
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause the actual results,
performance or achievements of Endexx to differ materially from
those implied or expressed by such forward-looking statements. This
press release speaks as of the date first set forth above, and
Endexx assumes no responsibility to update the information included
herein for events occurring after the date hereof. Actual results
could differ materially from those anticipated due to factors such
as the lack of capital, timely development of products, inability
to deliver products when ordered, inability of potential customer
to pay for ordered products, and political and economic risks
inherent in international trade.
SOURCE Endexx Corporation
